Byrne Asset Management »

Avalo Therapeutics shares owned by Byrne Asset Management

Quarter-by-quarter ownership of Avalo Therapeutics shares owned by Byrne Asset Management from 13F filings

Historical chart of Byrne Asset Management investment in Avalo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics by Byrne Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $89k 4.8k 18.48

Top funds holding Avalo Therapeutics